Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
11.61
+0.52 (4.69%)
At close: Jun 15, 2026, 4:00 PM EDT
11.35
-0.26 (-2.24%)
After-hours: Jun 15, 2026, 7:39 PM EDT
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $701.11 million as of June 15, 2026. Its market cap has decreased by -30.76% in one year.
Market Cap
701.11M
Enterprise Value
427.10M
1-Year Change
-30.76%
Ranking
Category
Stock Price
$11.61
Market Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $701.11M, an increase of 340.76%. That is a compound annual growth rate of 33.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 701.11M | -39.27% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evommune | 714.24M |
| Aura Biosciences | 707.02M |
| Solid Biosciences | 702.93M |
| Relmada Therapeutics | 697.52M |
| CorMedix | 685.67M |
| Design Therapeutics | 685.15M |
| Tenax Therapeutics | 675.92M |
| Allogene Therapeutics | 655.79M |